People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without the condition, new research has found. University of Manchester scientists used magnetic resonance imaging (MRI) scans to compare the brains of 26 men, half of whom had chronic psoriasis...

The National Institute for Health and Clinical Excellence (NICE) has today published final guidance recommending the use of alitretinoin as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids. In these cases, alitretinoin is recommended, within its licensed indication, if the person is assessed as having severe disease...

People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without the condition, new research has found. University of Manchester scientists used magnetic resonance imaging (MRI) scans to compare the brains of 26 men, half of whom had chronic psoriasis...

The National Institute for Health and Clinical Excellence (NICE) has today published final guidance recommending the use of alitretinoin as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids. In these cases, alitretinoin is recommended, within its licensed indication, if the person is assessed as having severe disease...

Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that the National Institute for Health and Clinical Excellence (NICE) issued its final guidance recommending the use of Toctino® (alitretinoin) within its licensed indication, as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids...